Contrast Nephropathy Associated FFA

Launched by SAGLIK BILIMLERI UNIVERSITESI · May 13, 2024

Keywords

ClinConnect Summary

It is known that patients are at risk of developing contrast nephropathy after FFA with iodinated contrast media. However, although it is known that contrast nephropathy may develop after FFA with fluorescein, a non-iodinated organic contrast agent, there is very limited data in the literature.

In this study, we aimed to determine the incidence of contrast nephropathy after FFA for retinopathy evaluation and to evaluate the associated factors (age, gender, diabetes mellitus, hypertension, chronic kidney disease, baseline renal function, medications, etc.). Our study was planned prospective...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Over 18 years old. Patients with an indication for FFA. Those who agreed to participate in the study.
• Exclusion Criteria:
• • Patients with nephrotoxic drug exposure in the last two weeks
• • Patients who underwent imaging management requiring the use of other contrast agents in the last month (such as coronary angiography, CT angiography)
• • Patients with unstable hemodynamics
• • Patients with obstructive uropathy
• • Patients with end-stage renal failure with eGFR\<15
• • Patients on a routine hemodialysis program